CD19 and neoplasm: CB CD19-CAR T cells displayed cytotoxicity targeting the CD19+ T cell lymphoma cell line BV173 and CD19+ DLBCL cell line SUDHL-4, triggered secretion of multiple cytokines in coculture assays, and limited tumor growth in a mouse model.